In addition to a potentially effective treatment for humans with HIV, the combination also shows potential to treat cats with leukemia.
A University of Minnesota research team featuring researchers from the Institute for Molecular Virology, School of Dentistry and Center for Drug Design has developed a new delivery system for a combination of two FDA approved drugs that may serve as an effective treatment for the human immunodeficiency virus (HIV).
The discovery, which allows for a combination of decitabine and gemcitabine to be delivered in pill form, marks a major step forward in patient feasibility for the drugs, which previously had been available solely via injection or intravenous therapy (IV).
The study, coauthored by Christine Clouser, Ph.D., Laurent Bonnac, Ph.D., Louis Mansky, Ph.D., and Steven Patterson, Ph.D., can be found “online first” in the journal Antiviral Chemistry & Chemotherapy.
“If you have a condition that requires you to take a medication everyday, as many patients with HIV do, you wouldn’t want to have to take that medication via daily injection,” said Steven Patterson, Ph.D., professor at the Center for Drug Design at the University of Minnesota. “This finding is a big step in demonstrating this treatment could be taken as a pill, similar to other HIV drugs, and is suitable for eventual clinical translation.”
University of Minnesota researchers first announced decitabine and gemcitabine could potentially combine to treat HIV in research published in August 2010. The drug combination was shown to work by lethal mutagenesis that could obliterate HIV by causing the virus to mutate to a point where it was no longer infectious. For some patients, HIV’s ability to quickly mutate and evolve can result in drug resistance. For patients who have developed resistance to currently available HIV treatments, the decitabine-gemcitabine drug combination could prove an effective alternative and secondary line of defense.
In addition to a potentially effective treatment for humans with HIV, the combination also shows potential to treat cats with leukemia.
The Latest Bing News on:
Decitabine and gemcitabine
- The Epigenome as a Therapeutic Target in Prostate Canceron April 29, 2024 at 5:00 pm
Antoinette S. Perry; R. William G. Watson; Mark Lawler; Donal Hollywood The final two classes of HDAC inhibitors consist of the electrophilic ketone, trifluoromethylketone, and the miscellaneous ...
- Bristol Myers: CHMP Recommends Approval Of Opdivo In Combination With Cisplatin And Gemcitabineon April 26, 2024 at 6:51 am
Bristol Myers Squibb (BMY) announced the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has ...
- Side Effectson April 16, 2024 at 4:01 am
Tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while using gemcitabine. Gemcitabine may harm an unborn baby. Your doctor should order a pregnancy ...
- Improving Cancer Care: The Role of Oral Hypomethylating Agents and Educationon April 14, 2024 at 5:00 pm
At present, patients have 2 approved options for HMAs. IV decitabine (Dacogen; MGI Pharma) and subcutaneous or IV azacitidine (Vidaza; Bristol Myers Squibb) are approved to treat MDS in the US.
- Weekly Gemcitabine and Trastuzumab in the Treatment of Patients with HER2-overexpressing Metastatic Breast Canceron April 7, 2024 at 5:00 pm
Background: The use of trastuzumab in combination with either a taxane or vinorelbine has improved the efficacy of treatment for women with HER2-positive (HER+) breast cancer. We investigated the ...
- What Is Decitabine And Common Side Effectson March 21, 2024 at 8:55 am
Decitabine is used in the treatment of type of blood cancer called acute myeloid leukaemia (AML). It is also used to treat patients with myelodysplastic syndrome (MDS). It may be used to treat ...
- Page settingson January 19, 2024 at 9:43 am
Cytarabine is used to treat various types of cancer. Gemcitabine is used to treat certain types of cancer (including breast, lung, ovarian, pancreatic). Etoposide is used to treat certain forms of ...
- Gemcitabine remains the standard of care for pancreatic canceron March 30, 2023 at 5:48 pm
Pancreatic cancer is the fourth leading cause of cancer death in the US, with over 35,000 deaths reported in 2009. 1 In 1997, gemcitabine became the standard of care for advanced disease and since ...
- Bio-Path Holdings Announces First Patient Dosed in Amended Stage 2 of the Phase 2 Clinical Trial Evaluating Prexigebersen in Acute Myeloid Leukemiaon August 12, 2020 at 5:00 pm
Despite the superior combination treatment results with LDAC, the new drug decitabine was favored by oncologists. As a result, Stage 2 of the Phase 2 trial in AML dropped the combination treatment ...
- Side effect(s) of Decitabineon March 18, 2018 at 7:50 am
Review the side-effects of Decitabine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...
The Latest Google Headlines on:
Decitabine and gemcitabine
[google_news title=”” keyword=”Decitabine and gemcitabine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
HIV
- Most Pregnant Women With HIV Don't Get Recommended Vaccinationson May 2, 2024 at 2:32 pm
Among 310 pregnancies in women living with HIV, the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine was administered to 32.6%, influenza vaccine to 31.6%, and both ...
- Study: HIV cases along border spiked during COVID-19 pandemicon May 2, 2024 at 2:01 pm
SAN DIEGO ( Border Report) — Researchers at UC San Diego and UC Irvine found that when border restrictions were in place during the COVID-19 pandemic, HIV transmissions in Tijuana and San Diego went ...
- “Vampire Facial” Trend Leaves Three Women With HIVon May 2, 2024 at 1:30 pm
Three women were diagnosed with HIV after receiving “vampire facials” at an unlicensed spa in New Mexico that reused disposable equipment, according to the results of a CDC investigation published ...
- R&B artist Raheem DeVaughn sings soulful tune for Gilead to combat HIVon May 2, 2024 at 1:06 pm
Grammy nominee and recording artist Raheem DeVaughn is working with Gilead Sciences to increase awareness of HIV preventive care among Black women.
- Gilead gets a boost from California court in a case over slow-walking an HIV drugon May 2, 2024 at 12:25 pm
The move by the California Supreme Court to review the case is seen as “very important,” according Evercore ISI analyst Umer Raffat.
- New HIV Infections After Vampire Facials at Unlicensed Spaon May 2, 2024 at 12:02 pm
The cosmetic procedures took place at a spa performing microneedling facials using unsterile injection practices.
- Funding cuts could have major impact on people living with HIVon May 1, 2024 at 1:43 pm
Whitehead said the impact of the funding cuts will be swift and severe. "Medical assistance is going to be overwhelmed. HIV cases are going to rise, and even the newly affected people, if you are ...
- Closing the US/Mexico border during COVID-19 increased HIV transmission, study findson May 1, 2024 at 6:12 am
The border crossing separating San Diego, California, from Tijuana, Mexico, is a dynamic place. When it was closed during the COVID-19 pandemic, drug tourism from San Diego to Tijuana continued. This ...
- GSK raises profit outlook on strong vaccine, HIV drug saleson May 1, 2024 at 3:14 am
GSK raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV medicines, though it expects sales growth to slow in the second half.
- 3 Women Contracted HIV From Vampire Facials. Here's What You Need to Knowon April 30, 2024 at 6:49 am
A CDC report found that 3 women contracted HIV from a beauty spa in New Mexico after receiving a vampire facial. Experts share tips on how to stay safe at your beauty appointment.
The Latest Google Headlines on:
HIV
[google_news title=”” keyword=”HIV” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]